About
Ension, Inc. is a medical device incubator that provides product development services, biocompatible surface modification, extracellular matrix and regenerative medicine scaffolds, and blood testing expertise. Ension, Inc was founded by Drs. Philip Litwak and Mark Gartner in 2001 to pursue design and development of novel medical technologies. The Company has expanded its infrastructure to include biocompatible surface design and biomaterial modification and testing as well as regenerative product development.
Technologies
Mobile Friendly
Google Analytics
Apache
Remote
Circle
Keywords
regenerative medicine scaffolds
ecmo
collagen processing & crosslinking
medical device product development
wound dressings & hemostats
biocompatible surfaces
biologics immobilization
cardiac & respiratory devices
bioactive heparin surfaces
biologic scaffolds
medical devices
regulatory compliance
antithrombogenic surfaces
implantable biomaterials
healthcare equipment & supplies
bioactive surface technology patent
blood-material interface optimization
medical equipment and supplies manufacturing
blood-contacting device coatings
biomaterial modification
medical technology
collagen matrix scaffolds
vascular prostheses
biomolecule immobilization
blood clot prevention surfaces
biotechnology
medical device surfaces
cgmp pilot manufacturing
medical device coating
government
Company Information
-
Employees 7
-
Founded 2001
-
Annual Revenue $7765000
Location
240 William Pitt Way, Pittsburgh, Pennsylvania, United States, 15238
